If you suffer from cancer or Parkinson’s disease, it’s possible that at least part of your treatment was developed at the Technion. Velcade, for the treatment of multiple myeloma, grew out of Nobel Prize winning research of Technion Professors Aaron Ciechanover and Avram Hershko. Azilect, for the treatment of Parkinson’s, was developed by Professor Emeritus Dr. Moussa Youdim, who is now helping to create the first-ever blood test for early diagnosis of the disease. And many promising research projects are underway for the treatment of heart disease.
The combination of engineering and medicine at the Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering has helped lay the foundation for a thriving medical device industry in Israel that has improved the quality of life for people all over the world. ReWalk and UPnRIDE (mobility devices for paraplegics and quadriplegics), Pillcam (capsule endoscopy) and the miniature surgical robots of Mazor Robotics and Microbot Medical were developed by Technion professors and alumni, as were the non-invasive tumor ablation systems of InSightec and the electric tumor treating fields of Novocure.
Technion Breakthroughs in Medical Research
Researchers Suggest New Theory for how Parkinson’s Disease Develops: Associate Professor Simone Engelender came up with a new hypothesis for Parkinson’s that could shift the paradigm on how the disease is viewed and treated.
A Biological Pacemaker: A Canadian-Israeli team of scientists led by Professor Lior Gepstein has developed a biological pacemaker that overcomes many of the limitations of electrical pacemakers.
Breakthrough Improves Chances Tissue Grafts Will Survive and Thrive: A better understanding of the effect of mechanical forces on blood vessel assembly in engineered tissues aids optimal growth of new blood vessels after tissue transplantation. Professor Shulamit Levenberg’s discovery would improve the chances that grafted tissues will survive.
Israeli Medical Startup Develops First Simple Blood Test for Parkinson’s Disease: A blood test underway for diagnosis of the disease is based on Professor Emeritus Moussa Youdim’s pioneering research.
Click below to watch more videos about Technion innovations in medical research:
Technion biophysicist Professor Kinneret Keren’s findings on how hydra regrow lost body parts might one day be useful for human tissue regeneration.
Professor Meytal Landau’s new approach to fighting the superbug could lead to new types of antibiotics.
Professor Moshe Shoham, Co-Founder of Mazor Robotics and Microbot Medical and head of the Technion’s Kahn Medical Robotics Laboratory, discusses the renaissance in robotic spine and brain surgery.